The obtained results clearly indicate that plasma renalase emerges to be a non-inferior biomarker in the prediction of ischemia in the HF cohort, compared to plasma BNP, emphasizing the relevance for the establishment of their subsequent comparative prognostic analyses and further confirmatory studies. This evidence concerns the gene NPPB and ischemia.